Search results for "Coronavirus"
New COVID-19 vaccine recommendations, data on after-effects of infection
The CDC recommended another COVID-19 booster for older patients and ended five-day isolation guidelines, while studies showed that COVID-19 infection was associated with a small cognitive decline and an increase in risk for autoimmune inflammatory rheumatic diseases.
https://immattersacp.org/weekly/archives/2024/03/05/4.htm
5 Mar 2024
One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound
A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023
Latest COVID-19 studies show need for repeat rapid testing, targeting of antiviral prescriptions
Viral load of SARS-CoV-2 doesn't peak until the fourth day of symptoms, one study found, while other research only saw an effect of nirmatrelvir/ritonavir on death and hospitalization among those who were moderately or severely immunocompromised, not in other high-risk groups.
https://immattersacp.org/weekly/archives/2023/10/03/2.htm
3 Oct 2023
CDC recommends COVID-19 booster; ACP updates practice points for outpatient treatment
Everyone ages 6 months and older should get an updated COVID-19 vaccine to protect against a potentially serious outbreak this fall and winter, the CDC said last week.
https://immattersacp.org/weekly/archives/2023/09/19/1.htm
19 Sep 2023
PASC defined, analyzed by latest COVID-19 studies
Two recent studies focused on postacute sequelae of SARS-CoV-2 (PASC), while another assessed the effectiveness of nirmatrelvir-ritonavir and molnupiravir in reducing morbidity and mortality from COVID-19.
https://immattersacp.org/weekly/archives/2023/06/06/2.htm
6 Jun 2023
ACP, Annals of Internal Medicine host forum on the end of the COVID-19 Public Health Emergency
A full recording of “COVID-19 Is No Longer a Public Health Emergency: Implications for Patients and Clinicians” is available online.
https://immattersacp.org/weekly/archives/2023/05/23/6.htm
23 May 2023
CBT improved severe fatigue after COVID-19, Dutch trial finds
After randomization, patients with severe fatigue three to 12 months after COVID-19 infection benefited from cognitive behavioral therapy (CBT) compared to usual care.
https://immattersacp.org/weekly/archives/2023/05/16/2.htm
16 May 2023
Register now for ACP and Annals of Internal Medicine's forum on the end of the COVID-19 Public Health Emergency
The virtual live event will be held on May 19 from 3:30 to 5 p.m. ET.
https://immattersacp.org/weekly/archives/2023/05/09/5.htm
9 May 2023
Studies look at effectiveness of bivalent booster, fluvoxamine plus inhaled budesonide for COVID-19
After four weeks, bivalent booster vaccines were 47.5% effective against hospitalization or death from COVID-19, a study in North Carolina found, while a Brazilian trial showed that fluvoxamine plus inhaled budesonide significantly reduced the risk of progression to severe disease among high-risk patients with symptomatic COVID-19.
https://immattersacp.org/weekly/archives/2023/04/18/2.htm
18 Apr 2023
COVID-19 rebound occurs with or without antivirals, doesn't affect outcomes, studies find
Rebound of both COVID-19 symptoms and viral load was rare in untreated, unvaccinated outpatients, one study showed, while another found similar rates of viral rebound in patients treated with nirmatrelvir-ritonavir, molnupiravir, or neither antiviral.
https://immattersacp.org/weekly/archives/2023/02/21/2.htm
21 Feb 2023